WO2019178980A1 - Method for preparing gynostemma pentaphylla makino saponin lvi, xlvi, l, li, damulin a or damulin b - Google Patents
Method for preparing gynostemma pentaphylla makino saponin lvi, xlvi, l, li, damulin a or damulin b Download PDFInfo
- Publication number
- WO2019178980A1 WO2019178980A1 PCT/CN2018/093947 CN2018093947W WO2019178980A1 WO 2019178980 A1 WO2019178980 A1 WO 2019178980A1 CN 2018093947 W CN2018093947 W CN 2018093947W WO 2019178980 A1 WO2019178980 A1 WO 2019178980A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silica gel
- gynostemma
- damulin
- saponin
- concentrated
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Definitions
- Gynostemma pentaphyllum (Thunb.) Makino, also known as nectar, genus, and roots, is a perennial herbaceous vine of the genus Gynostemma. It is mainly grown in the Qinling Mountains and south of the Yangtze River in China. It was first published in the Ming Dynasty's "Rescue Materia Medica” for wild vegetables. In the “Compendium of Materia Medica", it began to be used as the “blackberry”. "China Zhuang Pharmacy”: “Tongfu three ways and two ways, clearing away heat and detoxification, cough and phlegm.
- Gynostemma saponins LVI and XLVI are extracted and purified from Gynostemma pentaphyllum.
- Gynostemma saponins L, LI, Damulin A and Damulin B are extracted and purified by heat-treated Gynostemma pentaphyllum.
- Distiller by UPLC-MS of Four dammaranetype saponins from heat-processed Gynostemma pentaphyllum Bioscience, Biotechnology, and Biochemistry, 2014; Vol. 78, No. 2, 311-316.
- the unheated Gynostemma pentaphyllum L. saponins L, LI, Da Mulin A and Da Mulin B are very low, which is difficult to separate and purify; heating is complicated, and after heating, Gynostemma pentaphyllum L, LI, Damulin A and Damulin B
- the content is not increased synchronously, and the heating temperature and time are difficult to control (this phenomenon can also be reflected in the above cited documents).
- the present invention is directed to a method of preparing Gynostemma saponin LVI, XLVI, L, LI, Damulin A or Damulin B.
- step S1 the leaves of Gynostemma cardiospermum Cogn.ex Oliv are collected, dried in the air, extracted with an aqueous solution of ethanol and refluxed, filtered through a gauze, and the filtrate is concentrated to an alcohol-free taste;
- step S2 the extract concentrated to the non-alcoholic taste is applied to the D101 macroporous adsorption resin column, the resin diameter ratio is 1:10, and the mixed resin accounts for 1/10 of the total amount of the resin, and the wet packing is performed, and the resin is mixed.
- the sample was firstly eluted with 10BV of 30% ethanol at a flow rate of 10BV/h, and then eluted with 10BV of 85% ethanol at a flow rate of 10BV/h.
- the 3-10BV eluate was collected and concentrated to an alcohol-free atmosphere. Obtaining an aqueous solution of total sapon
- Step S5 respectively, collecting 20:1:2 dichloromethane/methanol/acetone eluting 7-8BV, 9-10BV eluent and concentrating and drying to obtain Damulin B and Damulin A; respectively collecting 10:1:2 dichloride Methane/methanol/acetone elution 3-4BV, 5-6BV eluate was concentrated and dried to obtain Gynostemma saponin L, Gynostemma saponin LI; 5:1:2 dichloromethane/methanol/acetone elution 4-5BV elution The solution was concentrated and dried to obtain Gynostemma saponin XLVI; the 2:1:2 dichloromethane/methanol/acetone eluted 2-3 BV eluate was concentrated and dried to obtain Gynostemma saponin LVI.
- 1 g of the total saponin aqueous solution is added to 50 g of the chitosan/attapulgite clay composite in step S3.
- the chitosan/attapulgite clay composite is added in step S3, stirred for 24 hours, allowed to stand for 2 hours, and then filtered.
- Step S2 microbial transformation: the seed culture was transferred to a conversion flask at a seeding rate of 5%, and pre-cultured at 28 ° C for 24 h, and then a sterile aqueous solution of Gynostemma pentaphyllum LI was added to make the final concentration of Gynostemma pentaphyllum LI 0.2 g/L, 28 ° C. Shake culture for 96h;
- Step S1 preparation of spores and seeds: inoculation of S. glabrata AS3.153 strain on slant medium, and incubating at 28 ° C for 7 days at constant temperature to obtain a culture with vigorous mycelium growth and spore-rich; taking appropriate amount of spores The seed bottle was shaken and cultured at 28 ° C for 24 h to obtain a seed culture;
- Step S2 microbial transformation: the seed culture was transferred to a conversion flask at a seeding rate of 5%, and pre-cultured at 28 ° C for 24 h, and then a sterile aqueous solution of Gynostemma pentaphyllum L was added to make the final concentration of Gynostemma pentaphyllum L 0.2 g/L, 28 ° C. Shake culture for 96h;
- the present invention finds that when the transformation raw material is Gynostemma pentaphyllum LI, the strain A. sinensis AS3.153 will be converted into Damulin A; when the transformation material is Gynostemma saponin L, the short thorn The .153 strain will convert it to Da Mulin B.
- the configuration of the C20 hydroxyl group of Gynostemma pentaphyllum LI and Gynostemma saponin L determines the dehydration selectivity of the strain A. sinensis AS3.153, and the strain of C. sinensis AS3.153 is selective for dehydration at this position. It is possible to selectively prepare Damulin A or Damulin B, and the utilization rate of raw materials is high.
- Figure 1 is a high performance liquid chromatographic spectrum of the aqueous solution of total saponin in step S2;
- step S3 is a high performance liquid chromatographic spectrum of the refined total saponin powder in step S3;
- Figure 10 is the HPLC analysis results of the crude product of the conversion product of Example 3.
- the upper figure shows the chromatogram of the reference solution (the synthesis of Damulin A and B monomers, the concentration is 0.1 mg/mL), and the figure below shows the chromatogram of the test solution.
- Figure prepared from the conversion product 0.5 mg in an appropriate amount of methanol).
- the chitosan/attapulgite clay composite preparation method comprises the following steps: 1 g of chitosan is dissolved in 100 mL of a 1% aqueous solution of acetic acid to obtain a chitosan sol, and 8 g of attapulgite clay is added to the sol, and stirred at room temperature for 48 hours. After standing for 2 h, the upper layer solution was poured out, and the residue was dried at 50 ° C, ground and dried.
- Different concentrations of ethanol refer to aqueous solutions of different volume percentages of ethanol.
- step S1 the leaves of Gynostemma cardiospermum Cogn.ex Oliv are collected, dried in the air, and extracted with a 75% by volume aqueous solution of ethanol, and the solid-liquid ratio is 1:20, and extracted 3 times, each time for 2 hours, gauze. Filtration, and the combined filtrates were concentrated to an alcohol-free taste;
- step S3 the total saponin aqueous solution is adjusted to pH 6.0 with hydrochloric acid, chitosan/attapulgite clay composite is added, and 1 g of total saponin aqueous solution is added to 50 g of chitosan/attapulgite clay composite, stirred for 24 hours, and allowed to stand for 2 h. After filtration, the filtrate is collected, the pH is adjusted to neutral by ammonia water, and lyophilized to obtain a refined total saponin powder;
- Step S5 respectively, collecting 20:1:2 dichloromethane/methanol/acetone eluting 7-8BV, 9-10BV eluent and concentrating and drying to obtain Damulin B and Damulin A; respectively collecting 10:1:2 dichloride Methane/methanol/acetone elution 3-4BV, 5-6BV eluate was concentrated and dried to obtain Gynostemma saponin L, Gynostemma saponin LI; 5:1:2 dichloromethane/methanol/acetone elution 4-5BV elution The solution was concentrated and dried to obtain Gynostemma saponin XLVI; the 2:1:2 dichloromethane/methanol/acetone eluted 2-3 BV eluate was concentrated and dried to obtain Gynostemma saponin LVI.
- Mobile phase A phase water (including pentadyltetrahydrofuran);
- Mobile phase B phase acetonitrile (including pentadyltetrahydrofuran);
- Injection volume 10 ⁇ L.
- step S2 that the total saponin aqueous solution obtained in step S2 has a complicated composition, and the impurity component in the refined total saponin is greatly reduced in step S3, indicating that the chitosan/attapulgite clay composite can effectively adsorb and remove total saponins at pH 6.0.
- the impurity component in the aqueous solution After removing impurities, it helps to reduce the difficulty of subsequent silica gel column chromatography.
- FIG. 6 High performance liquid chromatographic analysis of Gynostemma pentaphyllum L
- Figure 6 is a high performance liquid chromatographic analysis of Gynostemma pentaphyllum LI purified by silica gel column chromatography
- Figure 7 is a high performance liquid phase of Gynostemma saponin XLVI purified by silica gel column chromatography.
- Chromatographic analysis of the spectrum Figure 8 is a high performance liquid chromatographic analysis of Gynostemma saponin LVI purified by silica gel column chromatography.
- the purity of Gynostemma saponins LVI, XLVI, L, LI, Da Mulin A and Da Mulin B is very high, above 95%.
- Step S1 spore and seed preparation: the strain of C. sinensis AS3.153 preserved at 4 ° C was inoculated on a slant medium, and cultured at 28 ° C for 7 days at constant temperature to obtain a culture with vigorous hyphae growth and spore-rich; A spore-containing mycelium was taken by a sterile inoculating loop, and only the spores were placed in a seed bottle (50 mL medium in a 250 mL flask), and cultured at 28 ° C for 24 hours to obtain a seed culture;
- Step S3 the conversion product is collected: the supernatant of the transformation culture is taken, extracted three times with an equal volume of ethyl acetate, and the ethyl acetate extract is collected, and concentrated to dryness to obtain a crude conversion product;
- the slant medium is potato sucrose agar medium, the composition is: sucrose 1.5g, agar 2.0g, potato 20g and distilled water 100ml; seed bottle and transformation bottle medium composition: glucose 2.0g, yeast extract 0.5g, peptone 0.5 g, sodium chloride 0.5g, dipotassium hydrogen phosphate 0.5g and distilled water 100ml, the pH was adjusted to 8.3. After sterilization at 115 ° C for 30 min, use.
- a method for preparing Damulin B by microbial transformation method comprises the following steps:
- Step S1 spore and seed preparation: the strain of C. sinensis AS3.153 stored at 4 ° C was inoculated on the slant medium, and cultured at 28 ° C for 7 days at constant temperature to obtain a culture with strong mycelium growth and spore rich; A spore-containing mycelium was taken by a sterile inoculating loop, and only the spores were placed in a seed bottle (50 mL medium in a 250 mL flask), and cultured at 28 ° C for 24 hours to obtain a seed culture;
- the slant medium is potato sucrose agar medium, the composition is: sucrose 1.5g, agar 2.0g, potato 20g and distilled water 100ml; seed bottle and transformation bottle medium composition: glucose 2.0g, yeast extract 0.5g, peptone 0.5 g, sodium chloride 0.5g, dipotassium hydrogen phosphate 0.5g and distilled water 100ml, the pH was adjusted to 8.3. After sterilization at 115 ° C for 30 min, use.
- Chromatograph LC-20ADXR high pressure pump; SPD-M20A diode array UV visible light detector; CTO-20AC column oven; CBM-20A system controller; SIL-20ACXR autosampler;
- Mobile phase B phase acetonitrile (including pentadyltetrahydrofuran);
- Injection volume 10 ⁇ L.
- Figure 9 is the HPLC analysis results of the crude product of the conversion product of Example 2.
- the upper figure shows the chromatogram of the reference solution (the synthesis of Damulin A and B monomers, the concentration is 0.1 mg/mL), and the figure below shows the chromatogram of the test solution.
- Figure 10 is the HPLC analysis results of the crude product of the conversion product of Example 3.
- the upper figure shows the chromatogram of the reference solution (the synthesis of Damulin A and B monomers, the concentration is 0.1 mg/mL), and the figure below shows the chromatogram of the test solution.
- the strain A. sinensis AS3.153 when the transformation raw material is Gynostemma saponin LI, the strain A. sinensis AS3.153 will be basically converted into Damulin A; when the transformation raw material is Gynostemma saponin L, the short thorn is small.
- the C. sinensis AS3.153 strain will convert it to Damulin B.
- the configuration of the C20 hydroxyl group of Gynostemma pentaphyllum LI and Gynostemma saponin L determines the dehydration selectivity of the strain A. sinensis AS3.153, and the strain of C. sinensis AS3.153 is selective for dehydration at this position. It is possible to selectively prepare Damulin A or Damulin B, and the utilization rate of raw materials is high.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (9)
- 一种制备绞股蓝皂苷LVI、XLVI、L、LI、达木林A或达木林B的方法,其特征在于,包括通过如下步骤:A method for preparing Gynostemma saponin LVI, XLVI, L, LI, Damulin A or Damulin B, characterized in that it comprises the following steps:步骤S1,收集心籽绞股蓝Gynostemma cardiospermum Cogn.ex Oliv的叶,阴干,用乙醇水溶液加热回流提取,纱布过滤,合并滤液浓缩至无醇味;In step S1, the leaves of Gynostemma cardiospermum Cogn.ex Oliv are collected, dried in the air, extracted with an aqueous solution of ethanol and refluxed, filtered through a gauze, and the filtrate is concentrated to an alcohol-free taste;步骤S2,将浓缩至无醇味的提取液上样于D101大孔吸附树脂柱,树脂径高比为1:10,拌样树脂占树脂总量的1/10,湿法装柱,拌树脂上样;先用10BV的30%乙醇以10BV/h的流速洗脱除杂,再用10BV的85%乙醇以10BV/h的流速洗脱,收集3-10BV洗脱液,浓缩至无醇味得到总皂苷水溶液;In step S2, the extract concentrated to the non-alcoholic taste is applied to the D101 macroporous adsorption resin column, the resin diameter ratio is 1:10, and the mixed resin accounts for 1/10 of the total amount of the resin, and the wet packing is performed, and the resin is mixed. The sample was firstly eluted with 10BV of 30% ethanol at a flow rate of 10BV/h, and then eluted with 10BV of 85% ethanol at a flow rate of 10BV/h. The 3-10BV eluate was collected and concentrated to an alcohol-free atmosphere. Obtaining an aqueous solution of total sapon步骤S3,将总皂苷水溶液调节pH值至6.0,加入壳聚糖/凹凸棒石黏土复合物,常温搅拌、静置、过滤,收集滤液,调节pH值至中性,冷冻干燥得到精制总皂苷粉末;Step S3, adjusting the total saponin aqueous solution to pH value 6.0, adding chitosan/attapulgite clay composite, stirring at room temperature, standing, filtering, collecting filtrate, adjusting pH to neutral, and lyophilizing to obtain refined total saponin powder ;步骤S4,将精制总皂苷粉末上样于正相硅胶柱,硅胶径高比为1:10,拌样硅胶占硅胶总量的1/10,干法装柱,拌硅胶上样;依次用体积比为20:1:2、10:1:2、5:1:2、2:1:2的二氯甲烷/甲醇/丙酮混合溶剂以12BV/h的速度梯度洗脱,分别洗脱10BV、6BV、5BV、3BV;In step S4, the purified total saponin powder is applied to a normal phase silica gel column, the diameter ratio of the silica gel is 1:10, and the mixed silica gel accounts for 1/10 of the total amount of the silica gel. The dry method is packed in a column, and the silica gel is loaded; The ratio of 20:1:2, 10:1:2, 5:1:2, 2:1:2 of dichloromethane/methanol/acetone mixed solvent was eluted at a rate of 12 BV/h, and eluted 10 BV, 6BV, 5BV, 3BV;步骤S5,分别收集20:1:2二氯甲烷/甲醇/丙酮洗脱7-8BV、9-10BV的洗脱液浓缩干燥得到达木林B、达木林A;分别收集10:1:2二氯甲烷/甲醇/丙酮洗脱3-4BV、5-6BV的洗脱液浓缩干燥得到绞股蓝皂苷L、绞股蓝皂苷LI;收集5:1:2二氯甲烷/甲醇/丙酮洗脱4-5BV的洗脱液浓缩干燥得到绞股蓝皂苷XLVI;收集2:1:2二氯甲烷/甲醇/丙酮洗脱2-3BV的洗脱液浓缩干燥得到绞股蓝皂苷LVI。Step S5, respectively, collecting 20:1:2 dichloromethane/methanol/acetone eluting 7-8BV, 9-10BV eluent and concentrating and drying to obtain Damulin B and Damulin A; respectively collecting 10:1:2 dichloride Methane/methanol/acetone elution 3-4BV, 5-6BV eluate was concentrated and dried to obtain Gynostemma saponin L, Gynostemma saponin LI; 5:1:2 dichloromethane/methanol/acetone elution 4-5BV elution The solution was concentrated and dried to obtain Gynostemma saponin XLVI; the 2:1:2 dichloromethane/methanol/acetone eluted 2-3 BV eluate was concentrated and dried to obtain Gynostemma saponin LVI.
- 根据权利要求1所述的方法,其特征在于,壳聚糖/凹凸棒石黏土复合物制备方法为:1g壳聚糖溶于100mL质量分数为1%的醋酸水溶液中得到壳聚糖溶胶,向该溶胶中加入8g凹凸棒石黏土,常温搅拌48h,静置2h后将上层溶液倾倒出,剩余物50℃烘干,研磨、干燥。The method according to claim 1, wherein the chitosan/attapulgite clay composite is prepared by dissolving 1 g of chitosan in 100 mL of a 1% aqueous solution of acetic acid to obtain a chitosan sol. 8 g of attapulgite clay was added to the sol, and the mixture was stirred at room temperature for 48 hours. After standing for 2 hours, the upper layer solution was poured out, and the residue was dried at 50 ° C, ground and dried.
- 根据权利要求1所述的方法,其特征在于:步骤S1乙醇水溶液体积百分浓度为75%。The method according to claim 1, wherein the concentration of the aqueous ethanol solution in step S1 is 75% by volume.
- 根据权利要求3所述的方法,其特征在于:步骤S1提取的固液比为1:20。The method according to claim 3, wherein the solid-liquid ratio extracted in step S1 is 1:20.
- 根据权利要求1所述的方法,其特征在于:步骤S3中1L总皂苷水溶液加入50g壳聚糖/凹凸棒石黏土复合物。The method according to claim 1, characterized in that in step S3, 1 L of total saponin aqueous solution is added to 50 g of chitosan/attapulgite clay composite.
- 根据权利要求5所述的方法,其特征在于:步骤S3加入壳聚糖/凹凸棒石黏土复合物后搅拌24h,静置2h后过滤。The method according to claim 5, wherein the chitosan/attapulgite clay composite is added in step S3, stirred for 24 hours, allowed to stand for 2 hours, and then filtered.
- 根据权利要求1所述的方法,其特征在于:步骤S3用盐酸和氨水调节pH。The method of claim 1 wherein step S3 adjusts the pH with hydrochloric acid and aqueous ammonia.
- 一种微生物转化法制备达木林A的方法,其特征在于,包括通过如下步骤:A method for preparing Damulin A by microbial transformation method, comprising the steps of:步骤S1,孢子和种子制备:将短刺小克银汉霉AS3.153菌株接种于斜面培养基上,置于28℃恒温培养7d,得到菌丝生长旺盛、孢子丰富的培养物;取适量孢子接入种子瓶,于28℃ 振荡培养24h,得到种子培养物;Step S1, preparation of spores and seeds: inoculation of S. glabrata AS3.153 strain on slant medium, and incubating at 28 ° C for 7 days at constant temperature to obtain a culture with vigorous mycelium growth and spore-rich; taking appropriate amount of spores The seed bottle was shaken and cultured at 28 ° C for 24 h to obtain a seed culture;步骤S2,微生物转化:以5%的接种量将种子培养物转至转化瓶,28℃振荡预培养24h后加入绞股蓝皂苷LI无菌水溶液,使绞股蓝皂苷LI终浓度为0.2g/L,28℃振荡培养96h;Step S2, microbial transformation: the seed culture was transferred to a conversion flask at a seeding rate of 5%, and pre-cultured at 28 ° C for 24 h, and then a sterile aqueous solution of Gynostemma pentaphyllum LI was added to make the final concentration of Gynostemma pentaphyllum LI 0.2 g/L, 28 ° C. Shake culture for 96h;步骤S3,转化产物收集:取转化培养物上清液,用乙酸乙酯萃取,收集乙酸乙酯萃取液,浓缩得到转化产物粗品。Step S3, the conversion product was collected: the supernatant of the transformation culture was taken, extracted with ethyl acetate, and the ethyl acetate extract was collected and concentrated to obtain a crude product.步骤S4,将转化产物粗品上样于正相硅胶柱,硅胶径高比为1:10,拌样硅胶占硅胶总量的1/10,干法装柱,拌硅胶上样;依次用体积比为40:1:2、20:1:2的二氯甲烷/甲醇/丙酮混合溶剂以12BV/h的速度梯度洗脱,分别洗脱8BV、10BV;收集20:1:2二氯甲烷/甲醇/丙酮洗脱9-10BV的洗脱液浓缩干燥得到达木林A。Step S4, the crude product of the conversion product is applied to a normal phase silica gel column, the diameter ratio of the silica gel is 1:10, and the sampled silica gel accounts for 1/10 of the total amount of the silica gel. The dry method is packed in a column, and the silica gel is loaded; For 40:1:2, 20:1:2 dichloromethane/methanol/acetone mixed solvent, elute at a rate of 12 BV/h, elute 8BV, 10BV, respectively; collect 20:1:2 dichloromethane/methanol /acetic acid eluted 9-10 BV eluate was concentrated and dried to obtain Da Mulin A.
- 一种微生物转化法制备达木林B的方法,其特征在于,包括通过如下步骤:A method for preparing Damulin B by a microbial transformation method, comprising the steps of:步骤S1,孢子和种子制备:将短刺小克银汉霉AS3.153菌株接种于斜面培养基上,置于28℃恒温培养7d,得到菌丝生长旺盛、孢子丰富的培养物;取适量孢子接入种子瓶,于28℃振荡培养24h,得到种子培养物;Step S1, preparation of spores and seeds: inoculation of S. glabrata AS3.153 strain on slant medium, and incubating at 28 ° C for 7 days at constant temperature to obtain a culture with vigorous mycelium growth and spore-rich; taking appropriate amount of spores The seed bottle was shaken and cultured at 28 ° C for 24 h to obtain a seed culture;步骤S2,微生物转化:以5%的接种量将种子培养物转至转化瓶,28℃振荡预培养24h后加入绞股蓝皂苷L无菌水溶液,使绞股蓝皂苷L终浓度为0.2g/L,28℃振荡培养96h;Step S2, microbial transformation: the seed culture was transferred to a conversion flask at a seeding rate of 5%, and pre-cultured at 28 ° C for 24 h, and then a sterile aqueous solution of Gynostemma pentaphyllum L was added to make the final concentration of Gynostemma pentaphyllum L 0.2 g/L, 28 ° C. Shake culture for 96h;步骤S3,转化产物收集:取转化培养物上清液,用乙酸乙酯萃取,收集乙酸乙酯萃取液,浓缩得到转化产物粗品。Step S3, the conversion product was collected: the supernatant of the transformation culture was taken, extracted with ethyl acetate, and the ethyl acetate extract was collected and concentrated to obtain a crude product.步骤S4,将转化产物粗品上样于正相硅胶柱,硅胶径高比为1:10,拌样硅胶占硅胶总量的1/10,干法装柱,拌硅胶上样;依次用体积比为40:1:2、20:1:2的二氯甲烷/甲醇/丙酮混合溶剂以12BV/h的速度梯度洗脱,分别洗脱8BV、8BV;收集20:1:2二氯甲烷/甲醇/丙酮洗脱7-8BV的洗脱液浓缩干燥得到达木林B。Step S4, the crude product of the conversion product is applied to a normal phase silica gel column, the diameter ratio of the silica gel is 1:10, and the sampled silica gel accounts for 1/10 of the total amount of the silica gel. The dry method is packed in a column, and the silica gel is loaded; The 40:1:2, 20:1:2 dichloromethane/methanol/acetone mixed solvent was eluted at a rate of 12 BV/h, eluting 8BV, 8BV, respectively; collecting 20:1:2 dichloromethane/methanol /acetic acid eluted 7-8BV eluate was concentrated and dried to obtain Da Mulin B.
Applications Claiming Priority (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810243966.6A CN108179169B (en) | 2018-03-23 | 2018-03-23 | A kind of method that microbe transformation method prepares damulin A |
CN201810243934.6 | 2018-03-23 | ||
CN201810243217.3A CN108178778B (en) | 2018-03-23 | 2018-03-23 | A method of preparing damulin B |
CN201810243966.6 | 2018-03-23 | ||
CN201810243218.8A CN108484712B (en) | 2018-03-23 | 2018-03-23 | A method of preparing damulin A |
CN201810243192.7A CN108484711B (en) | 2018-03-23 | 2018-03-23 | A method of preparing gypenoside LI |
CN201810243192.7 | 2018-03-23 | ||
CN201810243155.6 | 2018-03-23 | ||
CN201810243289.8A CN108484713B (en) | 2018-03-23 | 2018-03-23 | A method of preparing gypenoside L |
CN201810243289.8 | 2018-03-23 | ||
CN201810243217.3 | 2018-03-23 | ||
CN201810243218.8 | 2018-03-23 | ||
CN201810243250.6 | 2018-03-23 | ||
CN201810243934.6A CN108410940B (en) | 2018-03-23 | 2018-03-23 | A kind of method that microbe transformation method prepares damulin B |
CN201810243250.6A CN108276466B (en) | 2018-03-23 | 2018-03-23 | A method of preparing gypenoside LVI |
CN201810243155.6A CN108440631B (en) | 2018-03-23 | 2018-03-23 | A method of preparing gypenoside XLVI |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019178980A1 true WO2019178980A1 (en) | 2019-09-26 |
Family
ID=67988172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/093947 WO2019178980A1 (en) | 2018-03-23 | 2018-07-01 | Method for preparing gynostemma pentaphylla makino saponin lvi, xlvi, l, li, damulin a or damulin b |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2019178980A1 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011007943A1 (en) * | 2009-07-17 | 2011-01-20 | 주식회사 티지 바이오텍 | Method for producing novel gynostemma pentaphyllum extracts having increased amounts of damulin a and damulin b and pharmaceutical composition for treating metabolic diseases using the same |
CN102552371A (en) * | 2012-01-16 | 2012-07-11 | 中央民族大学 | Gynostemma pentaphylla extractive and application thereof to preparing medicine for treating tumor |
CN103169725A (en) * | 2013-01-29 | 2013-06-26 | 中央民族大学 | Gynostemma pentaphyllum extract and application thereof in preparation of medicament for treating tumor |
CN103720740A (en) * | 2014-01-16 | 2014-04-16 | 中央民族大学 | Gynostemma pentaphylla extract and fungus transformation preparation method thereof |
CN103908486A (en) * | 2014-03-17 | 2014-07-09 | 中国农业大学 | Preparing method of gynostemma pentaphyllum extraction product rich in gypenosides |
KR101450571B1 (en) * | 2012-12-18 | 2014-10-15 | 재단법인 한국한방산업진흥원 | A Method for isolating damulin A and damulin A from Gynostemma pentaphyllum |
CN108179169A (en) * | 2018-03-23 | 2018-06-19 | 娄志春 | A kind of method that microbe transformation method prepares damulin A |
CN108178778A (en) * | 2018-03-23 | 2018-06-19 | 娄志春 | A kind of method for preparing damulin B |
-
2018
- 2018-07-01 WO PCT/CN2018/093947 patent/WO2019178980A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011007943A1 (en) * | 2009-07-17 | 2011-01-20 | 주식회사 티지 바이오텍 | Method for producing novel gynostemma pentaphyllum extracts having increased amounts of damulin a and damulin b and pharmaceutical composition for treating metabolic diseases using the same |
CN102552371A (en) * | 2012-01-16 | 2012-07-11 | 中央民族大学 | Gynostemma pentaphylla extractive and application thereof to preparing medicine for treating tumor |
KR101450571B1 (en) * | 2012-12-18 | 2014-10-15 | 재단법인 한국한방산업진흥원 | A Method for isolating damulin A and damulin A from Gynostemma pentaphyllum |
CN103169725A (en) * | 2013-01-29 | 2013-06-26 | 中央民族大学 | Gynostemma pentaphyllum extract and application thereof in preparation of medicament for treating tumor |
CN103720740A (en) * | 2014-01-16 | 2014-04-16 | 中央民族大学 | Gynostemma pentaphylla extract and fungus transformation preparation method thereof |
CN103908486A (en) * | 2014-03-17 | 2014-07-09 | 中国农业大学 | Preparing method of gynostemma pentaphyllum extraction product rich in gypenosides |
CN108179169A (en) * | 2018-03-23 | 2018-06-19 | 娄志春 | A kind of method that microbe transformation method prepares damulin A |
CN108178778A (en) * | 2018-03-23 | 2018-06-19 | 娄志春 | A kind of method for preparing damulin B |
Non-Patent Citations (3)
Title |
---|
LIU, HUIMIN ET AL.: "Microbial Transformation of Gypenoside XL VI by Lactobacillus Delbrueckii Subsp. Bulgaricus", FOOD SCIENCE, vol. 35, no. 17, 31 December 2014 (2014-12-31), pages 133 - 136 * |
LIU, HUIMIN ET AL.: "Saponins from Zhung-Medicine Gocaekmbaw before and after heat-Processing", CHINESE JOURNAL OF EXPERIMENTAL TRAD. MEDICAL FORMULAE, vol. 19, no. 15, 31 August 2013 (2013-08-31), pages 106 - 110, XP055640380 * |
PIAO, XIANGLAN ET AL.: "Microbial Transformation of Ethanol-Soluble Constituents from Gynostemma Pentaphyllum", FOOD SCIENCE, vol. 34, no. 21, 201331231, pages 149 - 153, XP055640387 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101260131A (en) | Method for extracting iridoid active site and monomer from eucommia bark | |
CN103204765A (en) | Method for extracting solanesol and chlorogenic acid from discard tobacco leaves | |
CN102976909A (en) | Method for extracting and purifying 6-gingerol from ginger | |
KR20130093372A (en) | Preparation method of oxyresveratrol, t-resveratrol, and moracin having anti-inflammatory and anti-aging function from mulberry twig extract | |
CN108103124A (en) | A kind of liquid state fermentation of Antrodia camphorata exocellular polysaccharide and purification process | |
CN105566414B (en) | The method that four kinds of flavone glycosides are isolated and purified from waxberry flesh | |
CN107098942B (en) | Method for subcritical water extraction of kaempferitrin in radish leaves | |
CN102526127B (en) | Flash type extraction method for active constituents in cordyceps militaris | |
CN108059628A (en) | A kind of fast preparation method of blueberry anthocyanin | |
CN101492350B (en) | Method for producing D-pinit from plant locust | |
WO2012061984A1 (en) | Method for preparing albiflorin and paeoniflorin | |
CN108640956A (en) | A method of preparing flavonoid glycoside from tea seed | |
WO2019184025A1 (en) | Method for preparing polyarabogalacturonic acid by using dried tangerine peel | |
CN103664610B (en) | Method for extracting chlorogenic acid from sweet potato leaves | |
CN107298687A (en) | Purification maackiain technique is extracted from beautiful millettia root | |
WO2019178980A1 (en) | Method for preparing gynostemma pentaphylla makino saponin lvi, xlvi, l, li, damulin a or damulin b | |
CN104257701B (en) | A kind of method for preparing ganoderma lucidum triterpene compounds | |
CN101492510A (en) | Method for purifying liquorice polyose | |
CN107325147A (en) | The screening technique of fulvoushair honeysuckle flower moderate resistance hypertensin conversion enzyme activity composition | |
CN101696381B (en) | Novel process for preparing highland barley flavone extract and application thereof in health wine | |
CN103289969A (en) | Method for extracting superoxide dismutase from plant stem leaves | |
CN102250174A (en) | Method for extracting jasminin from winter jasmine leaves | |
CN108997359A (en) | A method of chlorophyll is extracted from stevioside production waste residue | |
CN101618052A (en) | Process for extracting total flavonoids from hippophae leaves | |
CN109954009A (en) | A kind of joint production process extracting SOD and general flavone from leaf of Moringa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18911130 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18911130 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 10.03.2021) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18911130 Country of ref document: EP Kind code of ref document: A1 |